Concentra Group Holdings Parent, Inc.
CON Healthcare Medical Care Facilities
Concentra Group Holdings Parent, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 13.9% from fiscal 2024. In the quarter to June 2026, revenue grew 10.0%, EPS grew 45.7%, free cash flow grew 91.6% and total debt fell 5.54%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
Follow CON
Concentra Group Holdings Parent, Inc. (CON) EV/Sales
As of 16 October 2026, Concentra Group Holdings Parent, Inc. (CON) trades at a EV/Sales of 2.7×. Over the past ten years it has ranged from 1.4× (August 2024) to 2.8× (October 2026); the current reading is higher than 100% of that period. That is above the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.9× | (0.68%) |
| FY2024 | 1.9× | 29.89% |
| FY2023 | 1.4× | 0.00% |
| FY2022 | 1.4× | 0.00% |
| FY2021 | 1.4× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 2.2× | 19.01% |
| Mar 2026 | 1.9× | 1.57% |
| Dec 2025 | 1.9× | (8.55%) |
| Sep 2025 | 2.0× | (2.89%) |
| 8 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| OPCH Option Care Health, Inc. compare | 1.0× |
| PACS PACS Group, Inc. compare | 1.4× |
| ACHC Acadia Healthcare Company, Inc. compare | 1.5× |
| AVAH Aveanna Healthcare Holdings Inc. compare | 1.6× |
| GRDN Guardian Pharmacy Services, Inc. compare | 1.7× |
| NHC National HealthCare Corporation compare | 2.3× |
| CHE Chemed Corporation compare | 2.6× |
| CON Concentra Group Holdings Parent, Inc. | 2.7× |
| LFST LifeStance Health Group, Inc. compare | 2.9× |
| Medical Care Facilities industry median | 1.3× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)